Autonomyo

Autonomyo is a Swiss-based startup that operates in the healthcare technology sector, specifically focusing on mobility solutions for individuals with neurological gait disorders. The company's primary product is a lower limb exoskeleton designed to assist people with muscular and neurological deficiencies regain their ability to walk.

The company's business model revolves around providing a comprehensive service that includes individual fitting, a customised training program, and walking assistance. Autonomyo's solution is flexible, allowing patients to choose their training location, be it in a clinic, at a therapist's office, or in their own home. This flexibility not only enhances the convenience for the user but also allows for a more personalised approach to rehabilitation therapy.

Autonomyo's target market includes individuals with mobility impairments, therapists, and healthcare professionals. The company is also open to partnerships with patient groups and investors, indicating a potential for growth and expansion.

The company generates revenue by selling its exoskeleton product and related services. The pricing details are not publicly available, but it's likely that the cost is significant given the advanced technology involved. However, the value proposition is strong, as the product offers a solution to a problem that significantly impacts the quality of life for many people.

In summary, Autonomyo is a healthcare technology company that provides an innovative solution for people with mobility impairments. Its business model is centered on selling a high-tech exoskeleton and related services, with a focus on flexibility and personalisation.

Keywords: Healthcare Technology, Mobility Solutions, Neurological Gait Disorders, Lower Limb Exoskeleton, Rehabilitation Therapy, Personalised Service, Patient Groups, Partnerships, Investors, Quality of Life.